Tradestie Institutional Equity Comparison Engine

NTLA vs EDIT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EDIT Overall Edge

EDIT Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Editas Medicine, Inc. Common Stock (EDIT) driven by superior Growth & Margin, Options & Structure while NTLA counters with relative strength in Momentum & Technical. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus EDIT at N/M Forward P/E and -167.0% operating margin (+37.4% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NTLA N/M vs EDIT N/M Fwd P/E
Growth & Margin Winner EDIT
Op Margin -826.0% vs -167.0% ยท YoY -48.0% vs +37.4%
Momentum & Technical Winner NTLA
1Y +15.3% vs -25.0% ยท 52W Pos 20% vs 11%
Options & Structure Winner EDIT
BREAKDOWN (78th %ile IV) vs BREAKDOWN (38th %ile IV)
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NTLA +15.34% EDIT -25.0% Spread: +40.34 pp (NTLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NTLA Revenue EDIT Revenue NTLA Op. Margin EDIT Op. Margin Margin Edge
FY2018 $30M $30M -298.6% -356.1% NTLA
FY2019 $40M $20M -246.8% -686.4% NTLA
FY2020 $60M $90M -235.5% -148.6% EDIT
FY2021 $30M $30M -810.4% -756.1% EDIT
FY2022 $50M $20M -879.0% -1146.3% NTLA
FY2023 $40M $80M -1420.5% -216.6% EDIT
FY2024 $60M $30M -923.1% -777.2% EDIT
FY2025 $70M $40M -651.7% -394.9% EDIT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NTLA (5) vs EDIT (3)
Institutional Metric NTLA EDIT Criterion Row Winner
Market Capitalization Scale $1.5B $336.5M Larger Scale NTLA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -48.0% +37.4% Higher Growth EDIT
Operating Margin (TTM) Profitability -826.0% -167.0% Higher Margin EDIT
Net Profit Margin Profitability 0.0% -144.9% Higher Margin NTLA
Return on Equity (ROE) Capital Efficiency -62.6% -147.4% Higher ROE NTLA
52-Week Range Position Momentum 20% ($8โ€“$18) 11% ($2โ€“$4) Stronger Trend NTLA
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 2.32ฮฒ ยท 102% Vol Lower Realized Risk NTLA
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NTLA vs EDIT Buy Guide
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NTLA nor EDIT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.